-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Uczk96fnlkHbBT5qLR0Hz3McS0KihGwCythDaZg7HV5L0Qsflw8L9bYDiHfEvFGz sY8DLrD6DopzdKx/8aQf2w== 0000875320-08-000025.txt : 20080515 0000875320-08-000025.hdr.sgml : 20080515 20080515151652 ACCESSION NUMBER: 0000875320-08-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080513 FILED AS OF DATE: 20080515 DATE AS OF CHANGE: 20080515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Graves Kurt CENTRAL INDEX KEY: 0001406337 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 08836963 BUSINESS ADDRESS: BUSINESS PHONE: 617-444-6100 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-05-13 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406337 Graves Kurt C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2008-05-13 4 S 0 200 27.00 D 63874 D Common Stock 2008-05-13 4 S 0 2 27.07 D 63872 D Common Stock 2008-05-13 4 S 0 148 27.09 D 63724 D Common Stock 2008-05-13 4 S 0 1 27.12 D 63723 D Common Stock 2008-05-13 4 S 0 100 27.35 D 63623 D Common Stock 2008-05-13 4 S 0 100 27.38 D 63523 D Common Stock 2008-05-13 4 S 0 200 27.47 D 63323 D Common Stock 2008-05-13 4 S 0 200 27.63 D 63123 D Transaction made pursuant to Mr. Grave's company approved trading plan established under Rule 10b5-1. Valerie L. Andrews, Attorney-In-Fact 2008-05-15 -----END PRIVACY-ENHANCED MESSAGE-----